Sarnek J, Baran L
Arch Immunol Ther Exp (Warsz). 1975;23(4):511-6.
The influence of factors which inhibit 5-hydoxytryptamine (5-HT) synthesis, i.e. p-chlorophenylalanine (PCPA) and p-chloroamphetamine (PCA), on cataleptic action of the neuroleptics: spiroperiodol, pimozide, reserpine and fluphenazine was studied. PCPA showed weak anticataleptic activity in reserpine-induced catalepsy but had no effect on catalepsy induced by spiroperidol or fluphenazine. PCPA also tended to depress the cataleptic effect of pimozide, but the results were not statistically significant. PCA had no influence on catalepsy induced by neuroleptics from the group of butyrophenones, potentiated the cataleptic action of reserpine in the dose of 5 mg/kg, and suppressed catalepsy induced by reserpine in the dose of 10 mg/kg. The results suggest that under conditions of the inhibition of the inhibition of 5-HT synthesis the cataleptic action of some neuroleptics may be slightly modified.
研究了抑制5-羟色胺(5-HT)合成的因素,即对氯苯丙氨酸(PCPA)和对氯苯丙胺(PCA),对精神安定药:螺哌隆、匹莫齐特、利血平和氟奋乃静致僵作用的影响。PCPA在利血平诱导的僵住症中表现出微弱的抗僵住活性,但对螺哌啶醇或氟奋乃静诱导的僵住症没有影响。PCPA也倾向于降低匹莫齐特的僵住效应,但结果无统计学意义。PCA对丁酰苯类精神安定药诱导的僵住症没有影响,在5mg/kg剂量下增强了利血平的僵住作用,并在10mg/kg剂量下抑制了利血平诱导的僵住症。结果表明,在5-HT合成抑制受到抑制的情况下,某些精神安定药的僵住作用可能会略有改变。